Drug information for PREZISTA

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
SUSPENSION; ORAL EQ 100MG BASE/ML Prescription  (Reference Drug) DARUNAVIR ETHANOLATE darunavir JANSSEN PRODS 202895
2012-03-15 Label
2012-02-29 Letter
2011-12-27 Letter
2011-12-23 Label
TABLET; ORAL EQ 150MG BASE Prescription   DARUNAVIR ETHANOLATE darunavir JANSSEN PRODS 21976
2012-02-24 Label
2012-02-23 Letter
2012-02-15 Letter
2012-02-14 Label
2011-12-27 Letter
2011-12-23 Label
2011-10-25 Label
2011-10-24 Letter
2010-12-15 Letter
2010-12-13 Label
2010-05-03 Label
2010-04-29 Letter
2010-02-05 Letter
2010-02-05 Letter
2010-02-04 Label
2010-02-04 Label
2009-06-22 Label
2009-06-22 Label
2009-06-17 Letter
2009-06-17 Letter
2009-01-02 Label
2008-12-29 Letter
2008-11-07 Label
2008-10-23 Letter
2008-10-23 Letter
2008-03-12 Label
2008-03-12 Label
2008-03-11 Letter
2008-03-11 Letter
2008-02-27 Letter
2008-02-26 Label
2006-12-08 Other Important Information from FDA
2006-12-04 Letter
2006-11-22 Label
2006-09-06 Review
2006-06-28 Label
2006-06-27 Letter
TABLET; ORAL EQ 300MG BASE Discontinued   DARUNAVIR ETHANOLATE darunavir JANSSEN PRODS   "
TABLET; ORAL EQ 400MG BASE Prescription   DARUNAVIR ETHANOLATE darunavir JANSSEN PRODS   "
TABLET; ORAL EQ 600MG BASE Prescription  (Reference Drug) DARUNAVIR ETHANOLATE darunavir JANSSEN PRODS   "
TABLET; ORAL EQ 75MG BASE Prescription   DARUNAVIR ETHANOLATE darunavir JANSSEN PRODS   "

Drug Adverse Effects information for PREZISTA

Role code Indications Reaction # Reports
PS ABDOMINAL DISCOMFORT GASTROINTESTINAL DISORDER 2
PS ABDOMINAL DISCOMFORT HERPES ZOSTER 2
PS CONSTIPATION HEPATIC FUNCTION ABNORMAL 1
PS CONSTIPATION RASH MACULO-PAPULAR 1
PS CONSTIPATION RENAL IMPAIRMENT 1
PS DIARRHOEA GASTROINTESTINAL DISORDER 1
PS DIARRHOEA HERPES ZOSTER 1
PS FOETAL EXPOSURE DURING PREGNANCY CONGENITAL UTERINE ANOMALY 2
PS FUNGAL INFECTION HEPATIC FUNCTION ABNORMAL 1
PS FUNGAL INFECTION RASH MACULO-PAPULAR 1
PS FUNGAL INFECTION RENAL IMPAIRMENT 1
PS GASTRIC CANCER AORTIC ANEURYSM 2
PS GASTRIC CANCER ILIAC ARTERY STENOSIS 2
PS HERPES ZOSTER GASTROINTESTINAL DISORDER 2
PS HERPES ZOSTER HERPES ZOSTER 2
PS HIV ANTIBODY POSITIVE HEPATITIS B 4
PS HIV ANTIBODY POSITIVE IMMUNE RECONSTITUTION SYNDROME 4
PS HIV INFECTION ACCIDENT 1
PS HIV INFECTION ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2
PS HIV INFECTION ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 3
PS HIV INFECTION ALANINE AMINOTRANSFERASE INCREASED 4
PS HIV INFECTION ANAEMIA 3
PS HIV INFECTION ANTIVIRAL DRUG LEVEL BELOW THERAPEUTIC 3
PS HIV INFECTION AORTIC ANEURYSM 8
PS HIV INFECTION ASTHENIA 3
PS HIV INFECTION BASEDOW'S DISEASE 4
PS HIV INFECTION BLOOD BILIRUBIN INCREASED 4
PS HIV INFECTION CELL DEATH 3
PS HIV INFECTION COMPLETED SUICIDE 1
PS HIV INFECTION CONDITION AGGRAVATED 4
PS HIV INFECTION CRYPTOCOCCUS TEST POSITIVE 2
PS HIV INFECTION CYTOMEGALOVIRUS TEST POSITIVE 2
PS HIV INFECTION DEATH 2
PS HIV INFECTION DIARRHOEA 3
PS HIV INFECTION DRUG ABUSE 3
PS HIV INFECTION DYSPHAGIA 4
PS HIV INFECTION EOSINOPHILIA 3
PS HIV INFECTION FACE OEDEMA 1
PS HIV INFECTION GASTROINTESTINAL DISORDER 4
PS HIV INFECTION HAEMATOMA 4
PS HIV INFECTION HENOCH-SCHONLEIN PURPURA 3
PS HIV INFECTION HEPATIC ENCEPHALOPATHY 4
PS HIV INFECTION HEPATITIS 3
PS HIV INFECTION HEPATITIS A VIRUS TEST POSITIVE 3
PS HIV INFECTION HEPATOTOXICITY 4
PS HIV INFECTION HERPES ZOSTER 4
PS HIV INFECTION HOSPITALISATION 1
PS HIV INFECTION HYPERTHYROIDISM 1
PS HIV INFECTION ILIAC ARTERY STENOSIS 8
PS HIV INFECTION IMMUNE RECONSTITUTION SYNDROME 4
PS HIV INFECTION INTERNATIONAL NORMALISED RATIO 4
PS HIV INFECTION IRRITABILITY 3
PS HIV INFECTION ISCHAEMIC STROKE 4
PS HIV INFECTION MALAISE 1
PS HIV INFECTION MATERNAL EXPOSURE DURING PREGNANCY 9
PS HIV INFECTION MYOCARDIAL INFARCTION 1
PS HIV INFECTION NAUSEA 3
PS HIV INFECTION NECROSIS 4
PS HIV INFECTION NEOPLASM MALIGNANT 2
PS HIV INFECTION NEPHROLITHIASIS 1
PS HIV INFECTION NEUROPATHY PERIPHERAL 4
PS HIV INFECTION NEUTROPHIL COUNT DECREASED 2
PS HIV INFECTION OFF LABEL USE 1
PS HIV INFECTION OLIGOHYDRAMNIOS 6
PS HIV INFECTION ORAL MUCOSA EROSION 3
PS HIV INFECTION PROTHROMBIN TIME PROLONGED 4
PS HIV INFECTION RASH GENERALISED 4
PS HIV INFECTION RENAL FAILURE 1
PS HIV INFECTION RENAL FAILURE ACUTE 3
PS HIV INFECTION SUICIDE ATTEMPT 3
PS HIV INFECTION THROMBOCYTOPENIA 2
PS HIV INFECTION TONSILLAR DISORDER 4
PS HIV INFECTION VOMITING 3
PS HIV TEST POSITIVE DIARRHOEA 3
PS HIV TEST POSITIVE EMOTIONAL DISORDER 4
PS HIV TEST POSITIVE ERYTHEMA 3
PS HIV TEST POSITIVE EYE IRRITATION 3
PS HIV TEST POSITIVE FACE OEDEMA 3
PS HIV TEST POSITIVE PYREXIA 3
PS HIV TEST POSITIVE RASH MACULAR 3
PS HIV TEST POSITIVE RASH PUSTULAR 3
PS HIV TEST POSITIVE RENAL FAILURE 3
PS HIV TEST POSITIVE ROTATOR CUFF SYNDROME 4
PS HIV TEST POSITIVE SOMNOLENCE 4
PS HIV TEST POSITIVE TENOSYNOVITIS 4
PS HIV TEST POSITIVE VOMITING 3
PS HYPERTENSION AORTIC ANEURYSM 2
PS HYPERTENSION ILIAC ARTERY STENOSIS 2
PS HYPERTENSION ISCHAEMIC STROKE 1
PS IMMUNE RECONSTITUTION SYNDROME HYPOAESTHESIA 2
PS IMMUNE RECONSTITUTION SYNDROME MUSCULAR WEAKNESS 2
PS IMMUNE RECONSTITUTION SYNDROME TONGUE PARALYSIS 2
PS PHYTOTHERAPY CONDITION AGGRAVATED 1
PS PHYTOTHERAPY HAEMATOMA 1
PS PNEUMOCYSTIS JIROVECI PNEUMONIA HEPATIC FUNCTION ABNORMAL 1
PS PNEUMOCYSTIS JIROVECI PNEUMONIA RASH MACULO-PAPULAR 1
PS PNEUMOCYSTIS JIROVECI PNEUMONIA RENAL IMPAIRMENT 1
PS PRODUCT USED FOR UNKNOWN INDICATION ANAEMIA 1
PS PRODUCT USED FOR UNKNOWN INDICATION ANTIVIRAL DRUG LEVEL BELOW THERAPEUTIC 1
PS PRODUCT USED FOR UNKNOWN INDICATION BLOOD GLUCOSE ABNORMAL 1
PS PRODUCT USED FOR UNKNOWN INDICATION DIARRHOEA 2
PS PRODUCT USED FOR UNKNOWN INDICATION DRUG ABUSE 4
PS PRODUCT USED FOR UNKNOWN INDICATION HEPATIC FUNCTION ABNORMAL 10
PS PRODUCT USED FOR UNKNOWN INDICATION HYPEROSMOLAR STATE 1
PS PRODUCT USED FOR UNKNOWN INDICATION MATERNAL EXPOSURE DURING PREGNANCY 3
PS PRODUCT USED FOR UNKNOWN INDICATION NEOPLASM MALIGNANT 1
PS PRODUCT USED FOR UNKNOWN INDICATION NEPHROLITHIASIS 3
PS PRODUCT USED FOR UNKNOWN INDICATION NEUROPATHY PERIPHERAL 6
PS PRODUCT USED FOR UNKNOWN INDICATION OFF LABEL USE 1
PS PRODUCT USED FOR UNKNOWN INDICATION OLIGOHYDRAMNIOS 2
PS PRODUCT USED FOR UNKNOWN INDICATION PORPHYRIA NON-ACUTE 4
PS PRODUCT USED FOR UNKNOWN INDICATION RASH MACULO-PAPULAR 10
PS PRODUCT USED FOR UNKNOWN INDICATION RENAL FAILURE 2
PS PRODUCT USED FOR UNKNOWN INDICATION RENAL FAILURE ACUTE 5
PS PRODUCT USED FOR UNKNOWN INDICATION RENAL IMPAIRMENT 10
PS PRODUCT USED FOR UNKNOWN INDICATION THROMBOCYTOPENIA 1
PS PRODUCT USED FOR UNKNOWN INDICATION VOMITING 2
PS PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY HYPOAESTHESIA 4
PS PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY MUSCULAR WEAKNESS 4
PS PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY TONGUE PARALYSIS 4
PS PROPHYLAXIS HYPOAESTHESIA 4
PS PROPHYLAXIS MUSCULAR WEAKNESS 4
PS PROPHYLAXIS TONGUE PARALYSIS 4
PS VOMITING HEPATIC FUNCTION ABNORMAL 1
PS VOMITING RASH MACULO-PAPULAR 1
PS VOMITING RENAL IMPAIRMENT 1
SS ACQUIRED IMMUNODEFICIENCY SYNDROME DISSEMINATED TUBERCULOSIS 8
SS ACQUIRED IMMUNODEFICIENCY SYNDROME IMMUNE RECONSTITUTION SYNDROME 8
SS ACQUIRED IMMUNODEFICIENCY SYNDROME LUNG INFECTION 8
SS ANTIRETROVIRAL THERAPY ABORTION SPONTANEOUS 2
SS ANTIRETROVIRAL THERAPY ALANINE AMINOTRANSFERASE INCREASED 3
SS ANTIRETROVIRAL THERAPY ANAEMIA 3
SS ANTIRETROVIRAL THERAPY APHASIA 3
SS ANTIRETROVIRAL THERAPY APRAXIA 3
SS ANTIRETROVIRAL THERAPY ASPARTATE AMINOTRANSFERASE INCREASED 3
SS ANTIRETROVIRAL THERAPY CALCULUS URINARY 3
SS ANTIRETROVIRAL THERAPY CEREBRAL TOXOPLASMOSIS 3
SS ANTIRETROVIRAL THERAPY CHOLECYSTITIS 3
SS ANTIRETROVIRAL THERAPY CHOLELITHIASIS 3
SS ANTIRETROVIRAL THERAPY CONFUSIONAL STATE 3
SS ANTIRETROVIRAL THERAPY CONGENITAL ANOMALY IN OFFSPRING 5
SS ANTIRETROVIRAL THERAPY CYTOLYTIC HEPATITIS 3
SS ANTIRETROVIRAL THERAPY ERYTHROPENIA 3
SS ANTIRETROVIRAL THERAPY FOETAL GROWTH RESTRICTION 4
SS ANTIRETROVIRAL THERAPY GAMMA-GLUTAMYLTRANSFERASE INCREASED 3
SS ANTIRETROVIRAL THERAPY LEUKOPENIA 3
SS ANTIRETROVIRAL THERAPY LYMPHOPENIA 3
SS ANTIRETROVIRAL THERAPY MATERNAL EXPOSURE DURING PREGNANCY 9
SS ANTIRETROVIRAL THERAPY PORPHYRIA NON-ACUTE 3
SS ANTIRETROVIRAL THERAPY PREMATURE BABY 4
SS ANTIRETROVIRAL THERAPY STATUS EPILEPTICUS 3
SS ANTIRETROVIRAL THERAPY UTERINE LEIOMYOMA 6
SS ANTIRETROVIRAL THERAPY VOMITING 3
SS ANTIVIRAL TREATMENT ABORTION SPONTANEOUS 4
SS ANTIVIRAL TREATMENT CONGENITAL ANOMALY 5
SS ANTIVIRAL TREATMENT FOETAL EXPOSURE DURING PREGNANCY 5
SS ANTIVIRAL TREATMENT FOETAL GROWTH RESTRICTION 5
SS ANTIVIRAL TREATMENT PREMATURE BABY 5
SS CONVULSION IMMUNE RECONSTITUTION SYNDROME 3
SS CONVULSION RASH MACULO-PAPULAR 3
SS FACTOR IX DEFICIENCY BRAIN STEM HAEMORRHAGE 1
SS GASTRIC CANCER AORTIC ANEURYSM 2
SS GASTRIC CANCER ILIAC ARTERY STENOSIS 2
SS HIV INFECTION ABDOMINAL DISCOMFORT 8
SS HIV INFECTION ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 15
SS HIV INFECTION ALANINE AMINOTRANSFERASE INCREASED 6
SS HIV INFECTION ANAEMIA 3
SS HIV INFECTION ANAPHYLACTIC SHOCK 10
SS HIV INFECTION ANOGENITAL DYSPLASIA 3
SS HIV INFECTION ANOGENITAL WARTS 3
SS HIV INFECTION ANTIVIRAL DRUG LEVEL BELOW THERAPEUTIC 3
SS HIV INFECTION AORTIC ANEURYSM 8
SS HIV INFECTION APHASIA 5
SS HIV INFECTION ASPARTATE AMINOTRANSFERASE INCREASED 6
SS HIV INFECTION ASTHENIA 18
SS HIV INFECTION ATYPICAL MYCOBACTERIAL INFECTION 3
SS HIV INFECTION BLOOD TRIGLYCERIDES INCREASED 5
SS HIV INFECTION BRAIN STEM HAEMORRHAGE 4
SS HIV INFECTION CALCULUS URINARY 1
SS HIV INFECTION CARCINOMA IN SITU 3
SS HIV INFECTION CASTLEMAN'S DISEASE 15
SS HIV INFECTION CHOLECYSTITIS 1
SS HIV INFECTION CHOLELITHIASIS 1
SS HIV INFECTION CONDITION AGGRAVATED 4
SS HIV INFECTION CYTOLYTIC HEPATITIS 1
SS HIV INFECTION DERMATITIS EXFOLIATIVE 6
SS HIV INFECTION DIARRHOEA 6
SS HIV INFECTION DRUG INTOLERANCE 4
SS HIV INFECTION DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6
SS HIV INFECTION DRUG RESISTANCE 15
SS HIV INFECTION DYSPHAGIA 4
SS HIV INFECTION EOSINOPHILIA 6
SS HIV INFECTION FALL 4
SS HIV INFECTION FLATULENCE 4
SS HIV INFECTION GAMMA-GLUTAMYLTRANSFERASE INCREASED 5
SS HIV INFECTION GENERALISED ERYTHEMA 10
SS HIV INFECTION HAEMATOMA 4
SS HIV INFECTION HYPERBILIRUBINAEMIA 6
SS HIV INFECTION HYPONATRAEMIA 6
SS HIV INFECTION ILIAC ARTERY STENOSIS 8
SS HIV INFECTION IMMUNE RECONSTITUTION SYNDROME 7
SS HIV INFECTION IRRITABILITY 3
SS HIV INFECTION ISCHAEMIC STROKE 12
SS HIV INFECTION LYMPHOCYTE MORPHOLOGY ABNORMAL 6
SS HIV INFECTION MATERNAL EXPOSURE DURING PREGNANCY 3
SS HIV INFECTION NAUSEA 7
SS HIV INFECTION NECROSIS 4
SS HIV INFECTION OCULAR HYPERAEMIA 4
SS HIV INFECTION OCULAR ICTERUS 4
SS HIV INFECTION PANCYTOPENIA 15
SS HIV INFECTION PARAESTHESIA 8
SS HIV INFECTION PORPHYRIA NON-ACUTE 1
SS HIV INFECTION PYREXIA 6
SS HIV INFECTION RASH GENERALISED 4
SS HIV INFECTION RASH MACULO-PAPULAR 4
SS HIV INFECTION RENAL FAILURE 3
SS HIV INFECTION ROTATOR CUFF SYNDROME 4
SS HIV INFECTION SLEEP DISORDER 4
SS HIV INFECTION SUICIDE ATTEMPT 3
SS HIV INFECTION SWELLING 4
SS HIV INFECTION SYNOVIAL CYST 4
SS HIV INFECTION TENDONITIS 4
SS HIV INFECTION TENOSYNOVITIS 8
SS HIV INFECTION TONSILLAR DISORDER 4
SS HIV INFECTION VERTIGO 4
SS HIV INFECTION VOMITING 6
SS HIV INFECTION WEIGHT DECREASED 21
SS HYPERTENSION AORTIC ANEURYSM 2
SS HYPERTENSION ILIAC ARTERY STENOSIS 2
SS HYPERTENSION ISCHAEMIC STROKE 3
SS HYPERTENSION PARAESTHESIA 2
SS HYPOTHYROIDISM DRUG INTOLERANCE 1
SS HYPOTHYROIDISM FLATULENCE 1
SS HYPOTHYROIDISM NAUSEA 1
SS HYPOTHYROIDISM OCULAR ICTERUS 1
SS HYPOTHYROIDISM SLEEP DISORDER 1
SS HYPOTHYROIDISM SYNOVIAL CYST 1
SS HYPOTHYROIDISM TENDONITIS 1
SS HYPOTHYROIDISM TENOSYNOVITIS 1
SS HYPOTHYROIDISM VERTIGO 1
SS NEURALGIA BRAIN STEM HAEMORRHAGE 1
SS ORAL CANDIDIASIS BRAIN STEM HAEMORRHAGE 1
SS PHYTOTHERAPY CONDITION AGGRAVATED 1
SS PHYTOTHERAPY FALL 1
SS PHYTOTHERAPY HAEMATOMA 1
SS PNEUMONIA BRAIN STEM HAEMORRHAGE 1
SS PRODUCT USED FOR UNKNOWN INDICATION ALANINE AMINOTRANSFERASE INCREASED 12
SS PRODUCT USED FOR UNKNOWN INDICATION ANAEMIA 13
SS PRODUCT USED FOR UNKNOWN INDICATION ANTIVIRAL DRUG LEVEL BELOW THERAPEUTIC 1
SS PRODUCT USED FOR UNKNOWN INDICATION APHASIA 12
SS PRODUCT USED FOR UNKNOWN INDICATION APRAXIA 12
SS PRODUCT USED FOR UNKNOWN INDICATION ASPARTATE AMINOTRANSFERASE INCREASED 12
SS PRODUCT USED FOR UNKNOWN INDICATION ATYPICAL MYCOBACTERIAL INFECTION 5
SS PRODUCT USED FOR UNKNOWN INDICATION BLISTER 4
SS PRODUCT USED FOR UNKNOWN INDICATION CEREBRAL TOXOPLASMOSIS 12
SS PRODUCT USED FOR UNKNOWN INDICATION CONFUSIONAL STATE 12
SS PRODUCT USED FOR UNKNOWN INDICATION DIARRHOEA 2
SS PRODUCT USED FOR UNKNOWN INDICATION DRUG INTERACTION 5
SS PRODUCT USED FOR UNKNOWN INDICATION ERYTHROPENIA 12
SS PRODUCT USED FOR UNKNOWN INDICATION FOETAL GROWTH RESTRICTION 5
SS PRODUCT USED FOR UNKNOWN INDICATION GAMMA-GLUTAMYLTRANSFERASE INCREASED 12
SS PRODUCT USED FOR UNKNOWN INDICATION IMMUNE RECONSTITUTION SYNDROME 5
SS PRODUCT USED FOR UNKNOWN INDICATION ISCHAEMIC STROKE 8
SS PRODUCT USED FOR UNKNOWN INDICATION LEUKOPENIA 12
SS PRODUCT USED FOR UNKNOWN INDICATION LYMPHOPENIA 12
SS PRODUCT USED FOR UNKNOWN INDICATION MATERNAL EXPOSURE DURING PREGNANCY 6
SS PRODUCT USED FOR UNKNOWN INDICATION NEUROPATHY PERIPHERAL 5
SS PRODUCT USED FOR UNKNOWN INDICATION PARAESTHESIA 8
SS PRODUCT USED FOR UNKNOWN INDICATION PORPHYRIA NON-ACUTE 4
SS PRODUCT USED FOR UNKNOWN INDICATION PREMATURE BABY 5
SS PRODUCT USED FOR UNKNOWN INDICATION RENAL FAILURE 2
SS PRODUCT USED FOR UNKNOWN INDICATION RENAL FAILURE ACUTE 5
SS PRODUCT USED FOR UNKNOWN INDICATION STATUS EPILEPTICUS 12
SS PRODUCT USED FOR UNKNOWN INDICATION VOMITING 14
SS PROPHYLAXIS FOETAL GROWTH RESTRICTION 1
SS PROPHYLAXIS MATERNAL EXPOSURE DURING PREGNANCY 1
SS PROPHYLAXIS PREMATURE BABY 1
C ATRIAL FIBRILLATION ABDOMINAL PAIN UPPER 6
C ATRIAL FIBRILLATION DYSPEPSIA 2
C ATRIAL FIBRILLATION ERUCTATION 6
C ATRIAL FIBRILLATION FATIGUE 6
C ATRIAL FIBRILLATION NAUSEA 6
C ATRIAL FIBRILLATION WHITE BLOOD CELL COUNT DECREASED 6
C B-CELL LYMPHOMA HEPATITIS B 6
C BLOOD CHOLESTEROL INCREASED ABDOMINAL PAIN UPPER 3
C BLOOD CHOLESTEROL INCREASED DYSPEPSIA 1
C BLOOD CHOLESTEROL INCREASED ERUCTATION 3
C BLOOD CHOLESTEROL INCREASED FATIGUE 3
C BLOOD CHOLESTEROL INCREASED NAUSEA 3
C BLOOD CHOLESTEROL INCREASED WHITE BLOOD CELL COUNT DECREASED 3
C CRYOGLOBULINAEMIA ASTHENIA 1
C CRYOGLOBULINAEMIA DRUG INTERACTION 1
C CRYOGLOBULINAEMIA DYSPNOEA 1
C CRYOGLOBULINAEMIA GASTROENTERITIS 1
C CRYOGLOBULINAEMIA HYPERKALAEMIA 1
C CRYOGLOBULINAEMIA HYPOTENSION 1
C CRYOGLOBULINAEMIA METABOLIC ACIDOSIS 1
C CRYOGLOBULINAEMIA MUSCULAR WEAKNESS 1
C CRYOGLOBULINAEMIA PARAESTHESIA 1
C CRYOGLOBULINAEMIA PERITONITIS BACTERIAL 1
C CRYOGLOBULINAEMIA RENAL IMPAIRMENT 1
C DIABETES MELLITUS ABDOMINAL PAIN UPPER 15
C DIABETES MELLITUS DYSPEPSIA 5
C DIABETES MELLITUS ERUCTATION 15
C DIABETES MELLITUS FATIGUE 15
C DIABETES MELLITUS NAUSEA 15
C DIABETES MELLITUS WHITE BLOOD CELL COUNT DECREASED 15
C ERECTILE DYSFUNCTION RECTAL CANCER 3
C FACE AND MOUTH X-RAY ABNORMAL ABDOMINAL PAIN UPPER 3
C FACE AND MOUTH X-RAY ABNORMAL DYSPEPSIA 1
C FACE AND MOUTH X-RAY ABNORMAL ERUCTATION 3
C FACE AND MOUTH X-RAY ABNORMAL FATIGUE 3
C FACE AND MOUTH X-RAY ABNORMAL NAUSEA 3
C FACE AND MOUTH X-RAY ABNORMAL WHITE BLOOD CELL COUNT DECREASED 3
C HERPES SIMPLEX ABDOMINAL PAIN UPPER 3
C HERPES SIMPLEX DYSPEPSIA 1
C HERPES SIMPLEX ERUCTATION 3
C HERPES SIMPLEX FATIGUE 3
C HERPES SIMPLEX NAUSEA 3
C HERPES SIMPLEX WHITE BLOOD CELL COUNT DECREASED 3
C HIV INFECTION ABORTION INDUCED 6
C HIV INFECTION ABORTION SPONTANEOUS 11
C HIV INFECTION AGGRESSION 4
C HIV INFECTION ANGINA PECTORIS 8
C HIV INFECTION ANGIOEDEMA 3
C HIV INFECTION ASTHENIA 10
C HIV INFECTION BALANCE DISORDER 3
C HIV INFECTION BICYTOPENIA 2
C HIV INFECTION CORONARY ARTERY DISEASE 2
C HIV INFECTION DEATH 2
C HIV INFECTION DEEP VEIN THROMBOSIS 10
C HIV INFECTION DIALYSIS 1
C HIV INFECTION DRUG INTERACTION 3
C HIV INFECTION DYSPHAGIA 3
C HIV INFECTION DYSPNOEA 3
C HIV INFECTION ELECTROLYTE IMBALANCE 3
C HIV INFECTION FALL 3
C HIV INFECTION FANCONI SYNDROME 2
C HIV INFECTION FANCONI SYNDROME ACQUIRED 13
C HIV INFECTION NAUSEA 10
C HIV INFECTION OEDEMA PERIPHERAL 10
C HIV INFECTION OSTEOMALACIA 3
C HIV INFECTION OSTEOPOROSIS 3
C HIV INFECTION PAIN IN EXTREMITY 10
C HIV INFECTION PNEUMONIA 1
C HIV INFECTION PROTEINURIA 4
C HIV INFECTION RECTAL CANCER 12
C HIV INFECTION RENAL FAILURE 4
C HIV INFECTION RENAL FAILURE ACUTE 4
C HIV INFECTION RENAL TUBULAR NECROSIS 1
C HIV INFECTION RHABDOMYOLYSIS 3
C HIV INFECTION RIB FRACTURE 3
C HIV INFECTION SUICIDAL IDEATION 4
C HIV INFECTION THROMBOCYTOPENIA 3
C HIV INFECTION WRIST FRACTURE 3
C HIV INFECTION CDC CATEGORY B3 ASTHENIA 2
C HIV INFECTION CDC CATEGORY B3 DRUG INTERACTION 2
C HIV INFECTION CDC CATEGORY B3 DYSPNOEA 2
C HIV INFECTION CDC CATEGORY B3 GASTROENTERITIS 2
C HIV INFECTION CDC CATEGORY B3 HYPERKALAEMIA 2
C HIV INFECTION CDC CATEGORY B3 HYPOTENSION 2
C HIV INFECTION CDC CATEGORY B3 METABOLIC ACIDOSIS 2
C HIV INFECTION CDC CATEGORY B3 MUSCULAR WEAKNESS 2
C HIV INFECTION CDC CATEGORY B3 PARAESTHESIA 2
C HIV INFECTION CDC CATEGORY B3 PERITONITIS BACTERIAL 2
C HIV INFECTION CDC CATEGORY B3 RENAL IMPAIRMENT 2
C HIV TEST POSITIVE ABDOMINAL PAIN UPPER 12
C HIV TEST POSITIVE DYSPEPSIA 4
C HIV TEST POSITIVE ERUCTATION 12
C HIV TEST POSITIVE FATIGUE 12
C HIV TEST POSITIVE NAUSEA 12
C HIV TEST POSITIVE WHITE BLOOD CELL COUNT DECREASED 12
C HYPERCHOLESTEROLAEMIA RECTAL CANCER 3
C HYPERTENSION ABDOMINAL PAIN UPPER 6
C HYPERTENSION ASTHENIA 2
C HYPERTENSION DRUG INTERACTION 2
C HYPERTENSION DYSPEPSIA 2
C HYPERTENSION DYSPNOEA 2
C HYPERTENSION ERUCTATION 6
C HYPERTENSION FATIGUE 6
C HYPERTENSION GASTROENTERITIS 2
C HYPERTENSION HYPERKALAEMIA 2
C HYPERTENSION HYPOTENSION 2
C HYPERTENSION METABOLIC ACIDOSIS 2
C HYPERTENSION MUSCULAR WEAKNESS 2
C HYPERTENSION NAUSEA 6
C HYPERTENSION PARAESTHESIA 2
C HYPERTENSION PERITONITIS BACTERIAL 2
C HYPERTENSION RENAL IMPAIRMENT 2
C HYPERTENSION WHITE BLOOD CELL COUNT DECREASED 6
C LATENT TUBERCULOSIS BICYTOPENIA 1
C LATENT TUBERCULOSIS FANCONI SYNDROME ACQUIRED 1
C OEDEMA DUE TO HEPATIC DISEASE ASTHENIA 1
C OEDEMA DUE TO HEPATIC DISEASE DRUG INTERACTION 1
C OEDEMA DUE TO HEPATIC DISEASE DYSPNOEA 1
C OEDEMA DUE TO HEPATIC DISEASE GASTROENTERITIS 1
C OEDEMA DUE TO HEPATIC DISEASE HYPERKALAEMIA 1
C OEDEMA DUE TO HEPATIC DISEASE HYPOTENSION 1
C OEDEMA DUE TO HEPATIC DISEASE METABOLIC ACIDOSIS 1
C OEDEMA DUE TO HEPATIC DISEASE MUSCULAR WEAKNESS 1
C OEDEMA DUE TO HEPATIC DISEASE PARAESTHESIA 1
C OEDEMA DUE TO HEPATIC DISEASE PERITONITIS BACTERIAL 1
C OEDEMA DUE TO HEPATIC DISEASE RENAL IMPAIRMENT 1
C PAIN ANGINA PECTORIS 2
C PAIN CORONARY ARTERY DISEASE 2
C PAIN FANCONI SYNDROME 2
C PAIN FANCONI SYNDROME ACQUIRED 2
C PARKINSON'S DISEASE BALANCE DISORDER 1
C PARKINSON'S DISEASE DRUG INTERACTION 1
C PARKINSON'S DISEASE FALL 1
C PARKINSON'S DISEASE THROMBOCYTOPENIA 1
C PARKINSON'S DISEASE WRIST FRACTURE 1
C PRODUCT USED FOR UNKNOWN INDICATION ALOPECIA 1
C PRODUCT USED FOR UNKNOWN INDICATION ANGINA PECTORIS 4
C PRODUCT USED FOR UNKNOWN INDICATION ANGIOEDEMA 6
C PRODUCT USED FOR UNKNOWN INDICATION BLOOD CHOLESTEROL INCREASED 1
C PRODUCT USED FOR UNKNOWN INDICATION BLOOD TRIGLYCERIDES INCREASED 1
C PRODUCT USED FOR UNKNOWN INDICATION CHAPPED LIPS 1
C PRODUCT USED FOR UNKNOWN INDICATION DRUG INEFFECTIVE 1
C PRODUCT USED FOR UNKNOWN INDICATION DYSPHAGIA 6
C PRODUCT USED FOR UNKNOWN INDICATION DYSPNOEA 6
C PRODUCT USED FOR UNKNOWN INDICATION FANCONI SYNDROME ACQUIRED 4
C PRODUCT USED FOR UNKNOWN INDICATION HEPATITIS B 8
C PRODUCT USED FOR UNKNOWN INDICATION LIP EXFOLIATION 1
C PRODUCT USED FOR UNKNOWN INDICATION LIPIDS INCREASED 1
C PRODUCT USED FOR UNKNOWN INDICATION PHOTOPHOBIA 1
C PRODUCT USED FOR UNKNOWN INDICATION PNEUMONIA 2
C PRODUCT USED FOR UNKNOWN INDICATION VISION BLURRED 1
C PULMONARY ARTERIAL HYPERTENSION BURKITT'S LYMPHOMA 1
C PULMONARY ARTERIAL HYPERTENSION CONCOMITANT DISEASE PROGRESSION 2
C PULMONARY ARTERIAL HYPERTENSION LYMPHOMA 1
C TYPE 2 DIABETES MELLITUS ASTHENIA 2
C TYPE 2 DIABETES MELLITUS DRUG INTERACTION 2
C TYPE 2 DIABETES MELLITUS DYSPNOEA 2
C TYPE 2 DIABETES MELLITUS GASTROENTERITIS 2
C TYPE 2 DIABETES MELLITUS HYPERKALAEMIA 2
C TYPE 2 DIABETES MELLITUS HYPOTENSION 2
C TYPE 2 DIABETES MELLITUS METABOLIC ACIDOSIS 2
C TYPE 2 DIABETES MELLITUS MUSCULAR WEAKNESS 2
C TYPE 2 DIABETES MELLITUS PARAESTHESIA 2
C TYPE 2 DIABETES MELLITUS PERITONITIS BACTERIAL 2
C TYPE 2 DIABETES MELLITUS RENAL IMPAIRMENT 2
Ads by Google